{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T19:59:44Z","timestamp":1791921584856,"version":"4.3.4"},"reference-count":206,"publisher":"MDPI AG","issue":"16","license":[{"start":{"date-parts":[[2024,8,6]],"date-time":"2024-08-06T00:00:00Z","timestamp":1722902400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"research impact fund","award":["P0034588"],"award-info":[{"award-number":["P0034588"]}]},{"name":"research impact fund","award":["P00432219"],"award-info":[{"award-number":["P00432219"]}]},{"name":"internal dept funding","award":["P0034588"],"award-info":[{"award-number":["P0034588"]}]},{"name":"internal dept funding","award":["P00432219"],"award-info":[{"award-number":["P00432219"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Liquid biopsy, a noninvasive diagnosis that examines circulating tumor components in body fluids, is increasingly used in cancer management. An overview of relevant literature emphasizes the current state of liquid biopsy applications in cancer care. Biomarkers in liquid biopsy, particularly circulating tumor DNA (ctDNA), circulating tumor RNAs (ctRNA), circulating tumor cells (CTCs), extracellular vesicles (EVs), and other components, offer promising opportunities for early cancer diagnosis, treatment selection, monitoring, and disease assessment. The implementation of liquid biopsy in precision medicine has shown significant potential in various cancer types, including lung cancer, colorectal cancer, breast cancer, and prostate cancer. Advances in genomic and molecular technologies such as next-generation sequencing (NGS) and digital polymerase chain reaction (dPCR) have expanded the utility of liquid biopsy, enabling the detection of somatic variants and actionable genomic alterations in tumors. Liquid biopsy has also demonstrated utility in predicting treatment responses, monitoring minimal residual disease (MRD), and assessing tumor heterogeneity. Nevertheless, standardizing liquid biopsy techniques, interpreting results, and integrating them into the clinical routine remain as challenges. Despite these challenges, liquid biopsy has significant clinical implications in cancer management, offering a dynamic and noninvasive approach to understanding tumor biology and guiding personalized treatment strategies.<\/jats:p>","DOI":"10.3390\/ijms25168594","type":"journal-article","created":{"date-parts":[[2024,8,7]],"date-time":"2024-08-07T08:42:28Z","timestamp":1723020148000},"page":"8594","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":77,"title":["Liquid Biopsy in the Clinical Management of Cancers"],"prefix":"10.3390","volume":"25","author":[{"given":"Ho-Yin","family":"Ho","sequence":"first","affiliation":[{"name":"Department of Applied Biology & Chemical Technology, The Hong Kong Polytechnic University, Hong Kong SAR, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kei-See (Kasey)","family":"Chung","sequence":"additional","affiliation":[{"name":"Department of Applied Biology & Chemical Technology, The Hong Kong Polytechnic University, Hong Kong SAR, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chau-Ming","family":"Kan","sequence":"additional","affiliation":[{"name":"Department of Applied Biology & Chemical Technology, The Hong Kong Polytechnic University, Hong Kong SAR, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sze-Chuen (Cesar)","family":"Wong","sequence":"additional","affiliation":[{"name":"Department of Applied Biology & Chemical Technology, The Hong Kong Polytechnic University, Hong Kong SAR, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2024,8,6]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/bs.acc.2019.12.006","article-title":"Cell free DNA biology and its involvement in breast carcinogenesis","volume":"97","author":"Delmonico","year":"2020","journal-title":"Adv. Clin. Chem."},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"He, J., Xi, N., Han, Z., Luo, W., Shen, J., Wang, S., Li, J., Guo, Z., and Cheng, H. (2022). The Role of Liquid Biopsy Analytes in Diagnosis, Treatment and Prognosis of Colorectal Cancer. Front. Endocrinol., 13.","DOI":"10.3389\/fendo.2022.875442"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.critrevonc.2019.06.005","article-title":"Non-blood sources of cell-free DNA for cancer molecular profiling in clinical pathology and oncology","volume":"141","author":"Ponti","year":"2019","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1002\/elps.202200169","article-title":"Next-generation Liquid Biopsy Instruments: Challenges and Opportunities","volume":"44","author":"Zhu","year":"2023","journal-title":"Electrophoresis"},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Gao, W., Chen, Y., Yang, J., Zhuo, C., Zhang, H., and Shi, Y. (2021). Clinical Perspectives on Liquid Biopsy in Metastatic Colorectal Cancer. Front. Genet., 12.","DOI":"10.3389\/fgene.2021.634642"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"4000","DOI":"10.3748\/wjg.v24.i35.4000","article-title":"Changing Role of Histopathology in the Diagnosis and Management of Hepatocellular Carcinoma","volume":"24","author":"Rastogi","year":"2018","journal-title":"World J. Gastroenterol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"11769351221076062","DOI":"10.1177\/11769351221076062","article-title":"Liquid Biopsy: A Distinctive Approach to the Diagnosis and Prognosis of Cancer","volume":"21","author":"Hirahata","year":"2022","journal-title":"Cancer Inform."},{"key":"ref_8","first-page":"e50176","article-title":"Liquid Biopsy: An Evolving Paradigm for Non-invasive Disease Diagnosis and Monitoring in Medicine","volume":"15","author":"Adhit","year":"2023","journal-title":"Cureus"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1186\/s13046-020-01601-2","article-title":"Liquid biopsy and tumor heterogeneity in metastatic solid tumors: The potentiality of blood samples","volume":"39","author":"Russano","year":"2020","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Jin, N., Kan, C.-M., Pei, X.M., Cheung, W.L., Ng, S.S.M., Wong, H.T., Cheng, H.Y.-L., Leung, W.W., Wong, Y.N., and Tsang, H.F. (2023). Cell-free circulating tumor RNAs in plasma as the potential prognostic biomarkers in colorectal cancer. Front. Oncol., 13.","DOI":"10.3389\/fonc.2023.1134445"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"420","DOI":"10.21037\/tlcr.2016.08.06","article-title":"Pros: Can tissue biopsy be replaced by liquid biopsy?","volume":"5","author":"Ilie","year":"2016","journal-title":"Transl. Lung Cancer Res."},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Vidlarova, M., Rehulkova, A., Stejskal, P., Prokopova, A., Slavik, H., Hajduch, M., and Srovnal, J. (2023). Recent Advances in Methods for Circulating Tumor Cell Detection. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms24043902"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1186\/s40164-022-00352-4","article-title":"Understanding the versatile roles and applications of EpCAM in cancers: From bench to bedside","volume":"11","author":"Liu","year":"2022","journal-title":"Exp. Hematol. Oncol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1038\/s41392-021-00817-8","article-title":"Circulating tumor cells: Biology and clinical significance","volume":"6","author":"Lin","year":"2021","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1073274820934805","DOI":"10.1177\/1073274820934805","article-title":"Power and Promise of Next-Generation Sequencing in Liquid Biopsies and Cancer Control","volume":"27","author":"Wu","year":"2020","journal-title":"Cancer Control"},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Descamps, L., Le Roy, D., and Deman, A.-L. (2022). Microfluidic-Based Technologies for CTC Isolation: A Review of 10 Years of Intense Efforts towards Liquid Biopsy. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23041981"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.5306\/wjco.v12.i12.1169","article-title":"Detection of circulating tumour cells in colorectal cancer: Emerging techniques and clinical implications","volume":"12","author":"Yadav","year":"2021","journal-title":"World J. Clin. Oncol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1007\/s10585-024-10270-w","article-title":"Poor patient outcome correlates with active engulfment of cytokeratin positive CTCs within cancer-associated monocyte population in lung cancer","volume":"41","author":"Wiegmans","year":"2024","journal-title":"Clin. Exp. Metastasis"},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Armakolas, A., Kotsari, M., and Koskinas, J. (2023). Liquid Biopsies, Novel Approaches and Future Directions. Cancers, 15.","DOI":"10.3390\/cancers15051579"},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Habli, Z., AlChamaa, W., Saab, R., Kadara, H., and Khraiche, M.L. (2020). Circulating Tumor Cell Detection Technologies and Clinical Utility: Challenges and Opportunities. Cancers, 12.","DOI":"10.3390\/cancers12071930"},{"key":"ref_21","first-page":"4111","article-title":"Current methodologies to detect circulating tumor cells: A focus on ovarian cancer","volume":"11","author":"Lemma","year":"2021","journal-title":"Am. J. Cancer Res."},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Chu, P.Y., Hsieh, C.H., and Wu, M.H. (2020). The Combination of Immunomagnetic Bead-Based Cell Isolation and Optically Induced Dielectrophoresis (ODEP)-Based Microfluidic Device for the Negative Selection-Based Isolation of Circulating Tumor Cells (CTCs). Front. Bioeng. Biotechnol., 8.","DOI":"10.3389\/fbioe.2020.00921"},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Eslami-S, Z., Cort\u00e9s-Hern\u00e1ndez, L.E., and Alix-Panabi\u00e8res, C. (2020). Epithelial Cell Adhesion Molecule: An Anchor to Isolate Clinically Relevant Circulating Tumor Cells. Cells, 9.","DOI":"10.3390\/cells9081836"},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Fridrichova, I., Kalinkova, L., and Ciernikova, S. (2022). Clinical Relevancy of Circulating Tumor Cells in Breast Cancer: Epithelial or Mesenchymal Characteristics, Single Cells or Clusters?. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms232012141"},{"key":"ref_25","first-page":"1355","article-title":"Pathology of circulating tumor cells and the available capture tools (Review)","volume":"43","author":"Guan","year":"2020","journal-title":"Oncol. Rep."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"874","DOI":"10.2741\/4838","article-title":"Applications of RNA characterisation in circulating tumour cells","volume":"25","author":"Hassan","year":"2020","journal-title":"Front. Biosci.-Landmark"},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Schaffner, F., Merlin, J.-L., and von Bubnoff, N. (2020). Quantitative Analysis of Circulating Tumor Cells Using RNA-Based Digital Scoring. Tumor Liquid Biopsies, Springer.","DOI":"10.1007\/978-3-030-26439-0"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1790","DOI":"10.1038\/bjc.2012.137","article-title":"Viable circulating tumour cell detection using multiplex RNA in situ hybridisation predicts progression-free survival in metastatic breast cancer patients","volume":"106","author":"Payne","year":"2012","journal-title":"Br. J. Cancer"},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Bhatia, S., Wang, P., Toh, A., and Thompson, E.W. (2020). New Insights Into the Role of Phenotypic Plasticity and EMT in Driving Cancer Progression. Front. Mol. Biosci., 7.","DOI":"10.3389\/fmolb.2020.00071"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"2163","DOI":"10.1038\/s41467-019-10122-2","article-title":"Hydro-Seq enables contamination-free high-throughput single-cell RNA-sequencing for circulating tumor cells","volume":"10","author":"Cheng","year":"2019","journal-title":"Nat. Commun."},{"key":"ref_31","first-page":"25","article-title":"Improved platform for breast cancer circulating tumor cell enrichment and characterization with next-generation sequencing technology","volume":"13","author":"Mihalcioiu","year":"2023","journal-title":"Am. J. Cancer Res."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/s12291-020-00923-4","article-title":"Exploration of Circulating Tumour Cell (CTC) Biology: A Paradigm Shift in Liquid Biopsy","volume":"36","author":"Chauhan","year":"2021","journal-title":"Indian J. Clin. Biochem."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1016\/j.cell.2014.07.013","article-title":"Circulating Tumor Cell Clusters Are Oligoclonal Precursors of Breast Cancer Metastasis","volume":"158","author":"Aceto","year":"2014","journal-title":"Cell"},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Amintas, S., Bedel, A., Moreau-Gaudry, F., Boutin, J., Buscail, L., Merlio, J.-P., Vendrely, V., Dabernat, S., and Buscail, \u00c9. (2020). Circulating Tumor Cell Clusters: United We Stand Divided We Fall. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21072653"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"3468","DOI":"10.1021\/acs.analchem.2c05257","article-title":"Poly(ethylene Oxide) Concentration Gradient-Based Microfluidic Isolation of Circulating Tumor Cells","volume":"95","author":"Cheng","year":"2023","journal-title":"Anal. Chem."},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"Huang, Y., Li, X., Hou, J., Luo, Z., Yang, G., and Zhou, S. (2023). Conductive Nanofibers-Enhanced Microfluidic Device for the Efficient Capture and Electrical Stimulation-Triggered Rapid Release of Circulating Tumor Cells. Biosensors, 13.","DOI":"10.3390\/bios13050497"},{"key":"ref_37","unstructured":"Vivanco, M.D. (2022). Negative-Selection Enrichment of Circulating Tumor Cells from Peripheral Blood Using the Microfluidic CTC-iChip. Mammary Stem Cells: Methods and Protocols, Springer."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1038\/s41416-022-01819-1","article-title":"Functional analysis of circulating tumour cells: The KEY to understand the biology of the metastatic cascade","volume":"127","author":"Thomas","year":"2022","journal-title":"Br. J. Cancer"},{"key":"ref_39","doi-asserted-by":"crossref","unstructured":"Mazard, T., Cayrefourcq, L., Perriard, F., Senellart, H., Linot, B., de la Fouchardi\u00e8re, C., Terrebonne, E., Fran\u00e7ois, E., Obled, S., and Guimbaud, R. (2021). Clinical Relevance of Viable Circulating Tumor Cells in Patients with Metastatic Colorectal Cancer: The COLOSPOT Prospective Study. Cancers, 13.","DOI":"10.3390\/cancers13122966"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1007\/s13402-023-00774-0","article-title":"Circulating tumour cell isolation, analysis and clinical application","volume":"46","author":"Zhang","year":"2023","journal-title":"Cell. Oncol."},{"key":"ref_41","doi-asserted-by":"crossref","unstructured":"Budna-Tukan, J., \u015awierczewska, M., Mazel, M., Cie\u015blikowski, W.A., Ida, A., Jankowiak, A., Antczak, A., Nowicki, M., Pantel, K., and Azria, D. (2019). Analysis of Circulating Tumor Cells in Patients with Non-Metastatic High-Risk Prostate Cancer before and after Radiotherapy Using Three Different Enumeration Assays. Cancers, 11.","DOI":"10.3390\/cancers11060802"},{"key":"ref_42","doi-asserted-by":"crossref","unstructured":"Cayrefourcq, L., De Roeck, A., Garcia, C., Stoebner, P.-E., Fichel, F., Garima, F., Perriard, F., Daures, J.-P., Meunier, L., and Alix-Panabi\u00e8res, C. (2019). S100-EPISPOT: A New Tool to Detect Viable Circulating Melanoma Cells. Cells, 8.","DOI":"10.3390\/cells8070755"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1373\/clinchem.2019.305904","article-title":"Circulating Tumor Cells as a Prognostic Factor in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma: The CIRCUTEC Prospective Study","volume":"65","author":"Garrel","year":"2019","journal-title":"Clin. Chem."},{"key":"ref_44","doi-asserted-by":"crossref","unstructured":"de Miranda, F.S., Barauna, V.G., Dos Santos, L., Costa, G., Vassallo, P.F., and Campos, L.C.G. (2021). Properties and Application of Cell-Free DNA as a Clinical Biomarker. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22179110"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1038\/s41416-021-01610-8","article-title":"Extracellular vesicles as a source of prostate cancer biomarkers in liquid biopsies: A decade of research","volume":"126","author":"Line","year":"2022","journal-title":"Br. J. Cancer"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1186\/s12967-023-03960-8","article-title":"Liquid biopsies: The future of cancer early detection","volume":"21","author":"Connal","year":"2023","journal-title":"J. Transl. Med."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1038\/nrc.2017.7","article-title":"Liquid biopsies come of age: Towards implementation of circulating tumour DNA","volume":"17","author":"Wan","year":"2017","journal-title":"Nat. Rev. Cancer"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1016\/j.rpor.2020.07.007","article-title":"cfRNAs as biomarkers in oncology-still experimental or applied tool for personalized medicine already?","volume":"25","author":"Kolenda","year":"2020","journal-title":"Rep. Pract. Oncol. Radiother."},{"key":"ref_49","doi-asserted-by":"crossref","unstructured":"Zhang, C., Sun, C., Zhao, Y., Wang, Q., Guo, J., Ye, B., and Yu, G. (2022). Overview of MicroRNAs as Diagnostic and Prognostic Biomarkers for High-Incidence Cancers in 2021. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms231911389"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.omtn.2020.03.003","article-title":"The Promising Role of miR-21 as a Cancer Biomarker and Its Importance in RNA-Based Therapeutics","volume":"20","year":"2020","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"ref_51","doi-asserted-by":"crossref","unstructured":"Wang, W., Li, X., Liu, C., Zhang, X., Wu, Y., Diao, M., Tan, S., Huang, S., Cheng, Y., and You, T. (2022). MicroRNA-21 as a diagnostic and prognostic biomarker of lung cancer: A systematic review and meta-analysis. Biosci. Rep., 42.","DOI":"10.1042\/BSR20211653"},{"key":"ref_52","doi-asserted-by":"crossref","unstructured":"Nguyen, H.T., Kacimi, S.E.O., Nguyen, T.L., Suman, K.H., Lemus-Martin, R., Saleem, H., and Do, D.N. (2021). MiR-21 in the Cancers of the Digestive System and Its Potential Role as a Diagnostic, Predictive, and Therapeutic Biomarker. Biology, 10.","DOI":"10.3390\/biology10050417"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1007\/s11523-020-00717-x","article-title":"MicroRNAs (miRNAs) and Long Non-Coding RNAs (lncRNAs) as New Tools for Cancer Therapy: First Steps from Bench to Bedside","volume":"15","author":"Ratti","year":"2020","journal-title":"Target. Oncol."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.ncrna.2022.02.004","article-title":"Long noncoding RNAs as promising biomarkers in cancer","volume":"7","author":"Beylerli","year":"2022","journal-title":"Noncoding RNA Res."},{"key":"ref_55","doi-asserted-by":"crossref","unstructured":"Alcaide, M., Cheung, M., Hillman, J., Rassekh, S.R., Deyell, R.J., Batist, G., Karsan, A., Wyatt, A.W., Johnson, N., and Scott, D.W. (2020). Evaluating the quantity, quality and size distribution of cell-free DNA by multiplex droplet digital PCR. Sci. Rep., 10.","DOI":"10.1038\/s41598-020-69432-x"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1080\/10408363.2020.1750558","article-title":"Preanalytical variables that affect the outcome of cell-free DNA measurements","volume":"57","author":"Ungerer","year":"2020","journal-title":"Crit. Rev. Clin. Lab. Sci."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1373\/clinchem.2018.298323","article-title":"Guidelines for the Preanalytical Conditions for Analyzing Circulating Cell-Free DNA","volume":"65","author":"Meddeb","year":"2019","journal-title":"Clin. Chem."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"119729","DOI":"10.1016\/j.cca.2024.119729","article-title":"Effects of blood-processing protocols on cell-free DNA fragmentomics in plasma: Comparisons of one- and two-step centrifugations","volume":"560","author":"Hu","year":"2024","journal-title":"Clin. Chim. Acta"},{"key":"ref_59","doi-asserted-by":"crossref","unstructured":"Casadio, V., and Salvi, S. (2019). Cell-Free DNA: An Overview of Sample Types and Isolation Procedures. Cell-Free DNA as Diagnostic Markers: Methods and Protocols, Springer.","DOI":"10.1007\/978-1-4939-8973-7"},{"key":"ref_60","doi-asserted-by":"crossref","unstructured":"Diaz, I.M., Nocon, A., Held, S.A.E., Kobilay, M., Skowasch, D., Bronkhorst, A.J., Ungerer, V., Fredebohm, J., Diehl, F., and Holdenrieder, S. (2023). Pre-Analytical Evaluation of Streck Cell-Free DNA Blood Collection Tubes for Liquid Profiling in Oncology. Diagnostics, 13.","DOI":"10.3390\/diagnostics13071288"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1158\/1538-7445.AM2020-1965","article-title":"Abstract 1965: Multimodal analysis of circulating cell-free RNA (ccfRNA), cell-free DNA (ccfDNA) and genomic DNA (gDNA) from blood samples collected in PAXgene Blood ccfDNA Tubes","volume":"80","author":"Ullius","year":"2020","journal-title":"Cancer Res."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"e00125","DOI":"10.1016\/j.plabm.2019.e00125","article-title":"Comparison of Roche Cell-Free DNA collection Tubes\u00ae to Streck Cell-Free DNA BCT\u00aes for sample stability using healthy volunteers","volume":"16","author":"Parackal","year":"2019","journal-title":"Pract. Lab. Med."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/s40291-019-00442-w","article-title":"Specialized blood collection tubes for liquid biopsy: Improving the pre-analytical conditions","volume":"24","author":"Sorber","year":"2020","journal-title":"Mol. Diagn. Ther."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1038\/s41698-019-0107-0","article-title":"Precision cell-free DNA extraction for liquid biopsy by integrated microfluidics","volume":"4","author":"Lee","year":"2020","journal-title":"NPJ Precis. Oncol."},{"key":"ref_65","doi-asserted-by":"crossref","unstructured":"van der Leest, P., Boonstra, P.A., ter Elst, A., van Kempen, L.C., Tibbesma, M., Koopmans, J., Miedema, A., Tamminga, M., Groen, H.J.M., and Reyners, A.K.L. (2020). Comparison of Circulating Cell-Free DNA Extraction Methods for Downstream Analysis in Cancer Patients. Cancers, 12.","DOI":"10.3390\/cancers12051222"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.jmoldx.2024.01.008","article-title":"Extraction of Cell-Free DNA: Evaluation of Efficiency, Quantity, and Quality","volume":"26","author":"Terp","year":"2024","journal-title":"J. Mol. Diagn."},{"key":"ref_67","doi-asserted-by":"crossref","unstructured":"Tran, L.S., Pham, H.-A.T., Tran, V.T.T., Tran, T.T.T., Dang, A.-T.H., Le, D.-T.V., Nguyen, S.-L., Nguyen, N.-V., Nguyen, T., and Vo, B.T. (2019). Ultra-Deep Massively Parallel Sequencing with Unique Molecular Identifier Tagging Achieves Comparable Performance to Droplet Digital PCR for Detection and Quantification of Circulating Tumor DNA from Lung Cancer Patients. PLoS ONE, 14.","DOI":"10.1371\/journal.pone.0226193"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/s43046-022-00109-4","article-title":"Circulating tumor DNA in cancer diagnosis, monitoring, and prognosis","volume":"34","author":"Saha","year":"2022","journal-title":"J. Egypt. Natl. Cancer Inst."},{"key":"ref_69","doi-asserted-by":"crossref","unstructured":"Tamkovich, S., Tupikin,  A., Kozyakov, A., and Laktionov, P. (2022). Size and Methylation Index of Cell-Free and Cell-Surface-Bound DNA in Blood of Breast Cancer Patients in the Contest of Liquid Biopsy. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23168919"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/s13148-022-01283-x","article-title":"DNA Methylation Analysis of Tumor Suppressor Genes in Liquid Biopsy Components of Early Stage NSCLC: A Promising Tool for Early Detection","volume":"14","author":"Markou","year":"2022","journal-title":"Clin. Epigenet."},{"key":"ref_71","doi-asserted-by":"crossref","unstructured":"Liu, X., Lang, J., Li, S., Wang, Y., Peng, L., Wang, W., Han, Y., Qi, C., Song, L., and Yang, S. (2020). Fragment Enrichment of Circulating Tumor DNA with Low-Frequency Mutations. Front. Genet., 11.","DOI":"10.3389\/fgene.2020.00147"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1186\/s40246-023-00533-0","article-title":"Multidimensional Fragmentomic Profiling of Cell-Free DNA Released from Patient-Derived Organoids","volume":"17","author":"Kim","year":"2023","journal-title":"Human Genom."},{"key":"ref_73","doi-asserted-by":"crossref","unstructured":"Qi, T., Pan, M., Shi, H., Wang, L., Bai, Y.M., and Ge, Q. (2023). Cell-Free DNA Fragmentomics: The Novel Promising Biomarker. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms24021503"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1186\/s13046-024-03067-y","article-title":"Detection and Characterization of Pancreatic and Biliary Tract Cancers Using Cell-Free DNA Fragmentomics","volume":"43","author":"Shi","year":"2024","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"280","DOI":"10.21037\/tlcr-23-479","article-title":"Predicting Disease Recurrence in Limited Disease Small Cell Lung Cancer Using Cell-Free DNA-based Mutation and Fragmentome Analyses","volume":"13","author":"Park","year":"2024","journal-title":"Transl. Lung Cancer Res."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1158\/2767-9764.CRC-22-0456","article-title":"Integrated, Longitudinal Analysis of Cell-Free DNA in Uveal Melanoma","volume":"3","author":"Wong","year":"2023","journal-title":"Cancer Res. Commun."},{"key":"ref_77","doi-asserted-by":"crossref","unstructured":"Sundby, R.T., Szymanski, J.J., Pan, A., Jones, P.A., Mahmood, S.Z., Reid, O.H., Srihari, D., Armstrong, A.E., Chamberlain, S., and Burgic, S. (2024). Early Detection of Malignant and Pre-Malignant Peripheral Nerve Tumors Using Cell-Free DNA Fragmentomics. medRxiv.","DOI":"10.1101\/2024.01.18.24301053"},{"key":"ref_78","doi-asserted-by":"crossref","unstructured":"Maansson, C.T., Thomsen, L.S., Meldgaard, P., Nielsen, A.L., and Sorensen, B.S. (2024). Integration of Cell-Free DNA End Motifs and Fragment Lengths Can Identify Active Genes in Liquid Biopsies. Int. J. Mol. Sci., 25.","DOI":"10.3390\/ijms25021243"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"e2209852119","DOI":"10.1073\/pnas.2209852119","article-title":"Epigenetic Analysis of Cell-Free DNA by Fragmentomic Profiling","volume":"119","author":"Zhou","year":"2022","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_80","doi-asserted-by":"crossref","unstructured":"Stevic, I., Buescher, G., and Ricklefs, F.L. (2020). Monitoring Therapy Efficiency in Cancer through Extracellular Vesicles. Cells, 9.","DOI":"10.3390\/cells9010130"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"2783","DOI":"10.1016\/j.apsb.2021.01.001","article-title":"The biology, function, and applications of exosomes in cancer","volume":"11","author":"Liu","year":"2021","journal-title":"Acta Pharm. Sin. B"},{"key":"ref_82","doi-asserted-by":"crossref","unstructured":"Oliva, S., D\u2019Agostino, M., Boccadoro, M., and Larocca, A. (2020). Clinical Applications and Future Directions of Minimal Residual Disease Testing in Multiple Myeloma. Front. Oncol., 10.","DOI":"10.3389\/fonc.2020.00001"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1016\/j.ymthe.2020.06.003","article-title":"Exosomes: A Potential Therapeutic Tool Targeting Communications between Tumor Cells and Macrophages","volume":"28","author":"Guo","year":"2020","journal-title":"Mol. Ther."},{"key":"ref_84","doi-asserted-by":"crossref","unstructured":"Li, J., Guan, X., Fan, Z., Li, C., Li, Y., Wang, X., Cao, W., and Liu, D.X. (2020). Non-Invasive Biomarkers for Early Detection of Breast Cancer. Cancers, 12.","DOI":"10.3390\/cancers12102767"},{"key":"ref_85","doi-asserted-by":"crossref","unstructured":"Deun, J.V., Jo, A., Li, Y., Lin, H.K., Weissleder, R., Im, H., and Lee, H. (2020). Integrated Dual-Mode Chromatography to Enrich Extracellular Vesicles from Plasma. Adv. Biosyst., 4.","DOI":"10.1002\/adbi.201900310"},{"key":"ref_86","doi-asserted-by":"crossref","unstructured":"Vestad, B., Nyman, T.A., Hove-Skovsgaard, M., Stensland, M., Hoel, H., Tr\u00f8seid, A.-M.S., Aspelin, T., Aass, H.C.D., Puhka, M., and Hov, J.R. (2021). Potential Role of Plasma Extracellular Vesicles in Microbial Translocation and Cardiovascular Risk in People Living with HIV and Type 2 Diabetes. arXiv.","DOI":"10.21203\/rs.3.rs-577637\/v1"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"133","DOI":"10.3892\/ijo.2022.5423","article-title":"Isolation and Analysis of Tumor-derived Extracellular Vesicles from Head and Neck Squamous Cell Carcinoma Plasma by Galectin-based Glycan Recognition Particles","volume":"61","author":"Benecke","year":"2022","journal-title":"Int. J. Oncol."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1007\/s00216-022-04362-3","article-title":"Advancement and Obstacles in Microfluidics-Based Isolation of Extracellular Vesicles","volume":"415","author":"Havers","year":"2022","journal-title":"Anal. Bioanal. Chem."},{"key":"ref_89","doi-asserted-by":"crossref","unstructured":"Antounians, L., Tzanetakis, A., Pellerito, O., Catania, V.D., Sulistyo, A., Montalva, L., McVey, M.J., and Zani, A. (2019). The Regenerative Potential of Amniotic Fluid Stem Cell Extracellular Vesicles: Lessons Learned by Comparing Different Isolation Techniques. Sci. Rep., 9.","DOI":"10.1038\/s41598-018-38320-w"},{"key":"ref_90","doi-asserted-by":"crossref","unstructured":"Charrier, H., Beseme, O., Michel, J.B., Mulder, P., Amouyel, P., Pinet, F., and Turkieh, A. (2022). Lim Domain Binding 3 (Ldb3) Identified as a Potential Marker of Cardiac Extracellular Vesicles. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23137374"},{"key":"ref_91","doi-asserted-by":"crossref","unstructured":"Serrat\u00ec, S., Palazzo, A.J., Lapenna, A., Mateos, H., Mallardi, A., Marsano, R.M., Quarta, A., Rosso, M.D., and Azzariti, A. (2021). Salting-Out Approach Is Worthy of Comparison with Ultracentrifugation for Extracellular Vesicle Isolation from Tumor and Healthy Models. Biomolecules, 11.","DOI":"10.3390\/biom11121857"},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"2000094","DOI":"10.1002\/pmic.202000094","article-title":"Proteomic Profiling in Extracellular Vesicles for Cancer Detection and Monitoring","volume":"21","author":"Xue","year":"2021","journal-title":"Proteomics"},{"key":"ref_93","doi-asserted-by":"crossref","unstructured":"Bryl-G\u00f3recka, P., Olde, B., Gidl\u00f6f, O., T\u00f6rngren, K., and Erlinge, D. (2022). Increased Expression of miR-224-5p in Circulating Extracellular Vesicles of Patients with Reduced Coronary Flow Reserve. BMC Cardiovasc. Disord., 22.","DOI":"10.1186\/s12872-022-02756-w"},{"key":"ref_94","doi-asserted-by":"crossref","unstructured":"Tesovnik, T., Bizjan, B.J., \u0160ket, R., Debeljak, M., Battelino, T., and Kova\u010d, J. (2021). Technological Approaches in the Analysis of Extracellular Vesicle Nucleotide Sequences. Front. Bioeng. Biotechnol., 9.","DOI":"10.3389\/fbioe.2021.787551"},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1038\/s41392-023-01399-3","article-title":"Small molecule metabolites: Discovery of biomarkers and therapeutic targets","volume":"8","author":"Qiu","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1038\/s41571-020-00457-x","article-title":"Liquid Biopsy Enters the Clinic\u2014Implementation Issues and Future Challenges","volume":"18","author":"Ignatiadis","year":"2021","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"ref_97","doi-asserted-by":"crossref","unstructured":"Lee, B., Mahmud, I., Marchica, J., Derezi\u0144ski, P., Qi, F., Wang, F., Joshi, P., Valerio, F., Rivera, I., and Patel, V. (2020). Integrated RNA and Metabolite Profiling of Urine Liquid Biopsies for Prostate Cancer Biomarker Discovery. Sci. Rep., 10.","DOI":"10.1038\/s41598-020-60616-z"},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"2371","DOI":"10.21037\/tcr.2019.09.62","article-title":"Application of Metabolomics by UHPLC-MS\/MS in Diagnostics and Biomarker Discovery of Non-Small Cell Lung Cancer","volume":"8","author":"Liu","year":"2019","journal-title":"Transl. Cancer Res."},{"key":"ref_99","doi-asserted-by":"crossref","unstructured":"Wei, M., Zhao, X., Wang, P., Song, X., Hu, J., Zhong, K., Lei, L.-L., Xu, R., Han, W., and Yang, M. (2021). Novel Metabolic Biomarker for Early Detection and Prognosis to the Patients with Gastric Cardia Adnocarcinoma. arXiv.","DOI":"10.21203\/rs.3.rs-960379\/v1"},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1007\/s00535-016-1261-6","article-title":"Serum metabolomics analysis for early detection of colorectal cancer","volume":"52","author":"Uchiyama","year":"2017","journal-title":"J. Gastroenterol."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"3256","DOI":"10.1002\/ijc.32666","article-title":"Plasma metabolites associated with colorectal cancer stage: Findings from an international consortium","volume":"146","author":"Geijsen","year":"2020","journal-title":"Int. J. Cancer"},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1186\/s13046-024-03026-7","article-title":"Liquid Biopsy Techniques and Lung Cancer: Diagnosis, Monitoring and Evaluation","volume":"43","author":"Ren","year":"2024","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"ref_103","doi-asserted-by":"crossref","unstructured":"Lin, B., Jiang, J., Jia, J.M., and Zhou, X. (2022). Recent Advances in Exosomal miRNA Biosensing for Liquid Biopsy. Molecules, 27.","DOI":"10.3390\/molecules27217145"},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.4251\/wjgo.v13.i9.1210","article-title":"Use of Liquid Biopsies in Gastrointestinal Cancers","volume":"13","author":"Khachfe","year":"2021","journal-title":"World J. Gastrointest. Oncol."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"2735","DOI":"10.2147\/CMAR.S373165","article-title":"The Application of Liquid Biopsy Techniques in High-Risk Population for Hepatocellular Carcinoma","volume":"14","author":"Ding","year":"2022","journal-title":"Cancer Manag. Res."},{"key":"ref_106","doi-asserted-by":"crossref","unstructured":"Yan, T., Huang, J., Huang, S., Ahir, B.K., Li, L.-M., and Zhong, J.H. (2021). Advances in the Detection of Pancreatic Cancer Through Liquid Biopsy. Front. Oncol., 11.","DOI":"10.3389\/fonc.2021.801173"},{"key":"ref_107","doi-asserted-by":"crossref","unstructured":"Du, S., Zhao, Y., Lv, C., Wei, M., Gao, Z., and Meng, X. (2020). Applying Serum Proteins and MicroRNA as Novel Biomarkers for Early-Stage Cervical Cancer Detection. Sci. Rep., 10.","DOI":"10.1038\/s41598-020-65850-z"},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"26","DOI":"10.20517\/2394-4722.2022.13","article-title":"Current and Future Opportunities for Liquid Biopsy of Circulating Biomarkers to Aid in Early Cancer Detection","volume":"8","author":"Gawel","year":"2022","journal-title":"J. Cancer Metast. Treat."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"2160","DOI":"10.1002\/hep.31168","article-title":"Liquid Biopsies for Hepatocellular Cancer and Their Potential in Clinical Practice","volume":"71","author":"Jeffrey","year":"2020","journal-title":"Hepatology"},{"key":"ref_110","doi-asserted-by":"crossref","unstructured":"Wade, R., Nevitt, S., Liu, Y., Harden, M., Khouja, C., Raine, G., Churchill, R., and Dias, S. (2024). Multi-Cancer Early Detection Tests for General Population Screening: A Systematic Literature Review. medRxiv.","DOI":"10.1101\/2024.02.14.24302576"},{"key":"ref_111","doi-asserted-by":"crossref","unstructured":"Qvick, A., Bratulic, S., Carlsson, J., Stenmark, B., Karlsson, C., Nielsen, J., Gatto, F., and Helenius, G. (2024). Plasma Glycosaminoglycans and Cell-Free DNA to Discriminate Benign and Malignant Lung Diseases. medRxiv.","DOI":"10.1101\/2024.07.01.24309751"},{"key":"ref_112","doi-asserted-by":"crossref","unstructured":"Kan, C.M., Pei, X.M., Yeung, M.H.Y., Jin, N., Ng, S.S.M., Tsang, H.F., Cho, W.C.S., Yim, A.K., Yu, A.C., and Wong, S.C.C. (2023). Exploring the Role of Circulating Cell-Free RNA in the Development of Colorectal Cancer. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms241311026"},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1007\/s12032-023-01956-4","article-title":"Clinical Application of Liquid Biopsy in Endometrial Carcinoma","volume":"40","author":"Shen","year":"2023","journal-title":"Med. Oncol."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"8280","DOI":"10.1002\/jcb.28111","article-title":"A panel of noncoding RNAs in non-small-cell lung cancer","volume":"120","author":"Bagheri","year":"2019","journal-title":"J. Cell. Biochem."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.mam.2019.06.002","article-title":"Circulating biomarkers for early detection and clinical management of colorectal cancer","volume":"69","author":"Marcuello","year":"2019","journal-title":"Mol. Asp. Med."},{"key":"ref_116","doi-asserted-by":"crossref","unstructured":"Galv\u00e3o-Lima, L.J., Morais, A.H.F., Valentim, R.A.M., and Barreto, E.J.S.S. (2021). miRNAs as biomarkers for early cancer detection and their application in the development of new diagnostic tools. BioMed. Eng. Online, 20.","DOI":"10.1186\/s12938-021-00857-9"},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/s12943-022-01525-9","article-title":"Liquid Biopsy: Exosomal microRNAs as Novel Diagnostic and Prognostic Biomarkers in Cancer","volume":"21","author":"Preethi","year":"2022","journal-title":"Mol. Cancer"},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"2152","DOI":"10.1177\/15353702221110813","article-title":"Recent Advances in Nanotechnology-Enabled Biosensors for Detection of Exosomes as New Cancer Liquid Biopsy","volume":"247","author":"Hsu","year":"2022","journal-title":"Exp. Biol. Med."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"2640","DOI":"10.1002\/ijc.33386","article-title":"The Role of Exosomes in Liquid Biopsy for Cancer Diagnosis and Prognosis Prediction","volume":"148","author":"Li","year":"2020","journal-title":"Int. J. Cancer"},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"6617","DOI":"10.1021\/jacs.9b13874","article-title":"Antibody-Conjugated Signaling Nanocavities Fabricated by Dynamic Molding for Detecting Cancers Using Small Extracellular Vesicle Markers from Tears","volume":"142","author":"Takeuchi","year":"2020","journal-title":"J. Am. Chem. Soc."},{"key":"ref_121","doi-asserted-by":"crossref","unstructured":"Matsushita, D., Arigami, T., Okubo, K., Sasaki, K., Noda, M., Kita, Y., Mori, S., Uenosono, Y., Ohtsuka, T., and Natsugoe, S. (2020). The Diagnostic and Prognostic Value of a Liquid Biopsy for Esophageal Cancer: A Systematic Review and Meta-Analysis. Cancers, 12.","DOI":"10.3390\/cancers12103070"},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"5271","DOI":"10.2147\/CMAR.S170380","article-title":"Current Status of Liquid Biopsies for the Detection and Management of Prostate Cancer","volume":"11","author":"Lu","year":"2019","journal-title":"Cancer Manag. Res."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"61","DOI":"10.21037\/tau.2018.11.05","article-title":"The Current Role of Circulating Biomarkers in Non-Muscle Invasive Bladder Cancer","volume":"8","author":"Rink","year":"2019","journal-title":"Transl. Androl. Urol."},{"key":"ref_124","doi-asserted-by":"crossref","unstructured":"Lim, M., Kim, C.-J., Sunkara, V., Kim, M.H., and Cho, Y.K. (2018). Liquid Biopsy in Lung Cancer: Clinical Applications of Circulating Biomarkers (CTCs and ctDNA). Micromachines, 9.","DOI":"10.3390\/mi9030100"},{"key":"ref_125","doi-asserted-by":"crossref","unstructured":"Martins, I., Ribeiro, I.P., Jorge, J., Gon\u00e7alves, A.C., Sarmento-Ribeiro, A.B., Melo, J.B., and Carreira, I.M. (2021). Liquid Biopsies: Applications for Cancer Diagnosis and Monitoring. Genes, 12.","DOI":"10.3390\/genes12030349"},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"212","DOI":"10.3390\/gidisord2030022","article-title":"Circulating Tumour DNAs and Non-Coding RNAs as Liquid Biopsies for the Management of Colorectal Cancer Patients","volume":"2","author":"Lampis","year":"2020","journal-title":"Gastrointest. Disord."},{"key":"ref_127","doi-asserted-by":"crossref","unstructured":"Agashe, R., and Kurzrock, R. (2020). Circulating Tumor Cells: From the Laboratory to the Cancer Clinic. Cancers, 12.","DOI":"10.3390\/cancers12092361"},{"key":"ref_128","doi-asserted-by":"crossref","unstructured":"Nagayama, S., Low, S.K., and Kiyotani, K. (2021). Precision Medicine for Colorectal Cancer with Liquid Biopsy and Immunotherapy. Cancers, 13.","DOI":"10.3390\/cancers13194803"},{"key":"ref_129","doi-asserted-by":"crossref","unstructured":"Sardarabadi, P., Kojabad, A.A., Jafari, D., and Liu, C.-H. (2021). Liquid Biopsy-Based Biosensors for MRD Detection and Treatment Monitoring in Non-Small Cell Lung Cancer (NSCLC). Biosensors, 11.","DOI":"10.3390\/bios11100394"},{"key":"ref_130","doi-asserted-by":"crossref","unstructured":"Stergiopoulou, D., Markou, A., Strati, A., Zavridou, M., Tzanikou, E., Mastoraki, S., Kallergi, G., Georgoulias, V., and Lianidou, E. (2023). Comprehensive Liquid Biopsy Analysis as a Tool for the Early Detection of Minimal Residual Disease in Breast Cancer. Sci. Rep., 13.","DOI":"10.1038\/s41598-022-25400-1"},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.3390\/curroncol29030120","article-title":"Circulating Tumor DNA in Gastric and Gastroesophageal Junction Cancer","volume":"29","author":"Paschold","year":"2022","journal-title":"Curr. Oncol."},{"key":"ref_132","doi-asserted-by":"crossref","unstructured":"Pardini, B., Sabo, A.A., Birolo, G., and Calin, G.A. (2019). Noncoding RNAs in Extracellular Fluids as Cancer Biomarkers: The New Frontier of Liquid Biopsies. Cancers, 11.","DOI":"10.3390\/cancers11081170"},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1159\/000495615","article-title":"Potential of Liquid Biopsies for Breast Cancer Screening, Diagnosis, and Response to Treatment","volume":"96","author":"Saarenheimo","year":"2019","journal-title":"Oncology"},{"key":"ref_134","doi-asserted-by":"crossref","unstructured":"Yang, J., Hu, J., Li, Y., Luo, W., Liu, J., and Ye, D. (2022). Clinical Applications of Liquid Biopsy in Hepatocellular Carcinoma. Front. Oncol., 12.","DOI":"10.3389\/fonc.2022.781820"},{"key":"ref_135","doi-asserted-by":"crossref","unstructured":"Ye, S., You, Q., Song, S., Wang, H., Wang, C., Zhu, L., and Yang, Y. (2022). Nanostructures and Nanotechnologies for the Detection of Extracellular Vesicle. Adv. Biol., 7.","DOI":"10.1002\/adbi.202200201"},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"229","DOI":"10.3322\/caac.21834","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J. Clin."},{"key":"ref_137","doi-asserted-by":"crossref","unstructured":"Di Capua, D., Bracken-Clarke, D., Ronan, K., Baird, A.-M., and Finn, S. (2021). The Liquid Biopsy for Lung Cancer: State of the Art, Limitations and Future Developments. Cancers, 13.","DOI":"10.3390\/cancers13163923"},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s12943-022-01505-z","article-title":"Liquid biopsy in lung cancer: Significance in diagnostics, prediction, and treatment monitoring","volume":"21","author":"Li","year":"2022","journal-title":"Mol. Cancer"},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.1007\/s00432-020-03267-x","article-title":"Comparison of liquid-based to tissue-based biopsy analysis by targeted next generation sequencing in advanced non-small cell lung cancer: A comprehensive systematic review","volume":"146","author":"Esagian","year":"2020","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/s12943-022-01534-8","article-title":"Integration of liquid biopsy and pharmacogenomics for precision therapy of EGFR mutant and resistant lung cancers","volume":"21","author":"Kolesar","year":"2022","journal-title":"Mol. Cancer"},{"key":"ref_141","doi-asserted-by":"crossref","unstructured":"Jensen, S.G., Epistolio, S., Madsen, C.L., Kyneb, M.H., Riva, A., Paganotti, A., Barizzi, J., Petersen, R.K., B\u00f8rgesen, M., and Molinari, F. (2021). A new sensitive and fast assay for the detection of EGFR mutations in liquid biopsies. PLoS ONE, 16.","DOI":"10.1371\/journal.pone.0253687"},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.lungcan.2020.07.014","article-title":"Mechanisms of osimertinib resistance and emerging treatment options","volume":"147","author":"Schmid","year":"2020","journal-title":"Lung Cancer"},{"key":"ref_143","doi-asserted-by":"crossref","unstructured":"Del Re, M., Crucitta, S., Gianfilippo, G., Passaro, A., Petrini, I., Restante, G., Michelucci, A., Fogli, S., de Marinis, F., and Porta, C. (2019). Understanding the Mechanisms of Resistance in EGFR-Positive NSCLC: From Tissue to Liquid Biopsy to Guide Treatment Strategy. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20163951"},{"key":"ref_144","doi-asserted-by":"crossref","unstructured":"Mazzitelli, C., Santini, D., Corradini, A.G., Zamagni, C., Trer\u00e8, D., Montanaro, L., and Taffurelli, M. (2023). Liquid Biopsy in the Management of Breast Cancer Patients: Where Are We Now and Where Are We Going. Diagnostics, 13.","DOI":"10.3390\/diagnostics13071241"},{"key":"ref_145","first-page":"e43650","article-title":"The Emerging Role of Liquid Biopsies in Revolutionising Cancer Diagnosis and Therapy","volume":"15","author":"Shegekar","year":"2023","journal-title":"Cureus"},{"key":"ref_146","doi-asserted-by":"crossref","unstructured":"Orrantia-Borunda, E., Anchondo-Nu\u00f1ez, P., Acu\u00f1a-Aguilar, L.E., G\u00f3mez-Valles, F.O., and Ram\u00edrez-Valdespino, C.A. (2022). Subtypes of Breast Cancer. Breast Cancer [Internet], Exon Publications.","DOI":"10.36255\/exon-publications-breast-cancer-subtypes"},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"e2971","DOI":"10.6061\/clinics\/2021\/e2971","article-title":"Comparison of hormonal receptor expression and HER2 status between circulating tumor cells and breast cancer metastases","volume":"76","author":"Sanches","year":"2021","journal-title":"Clinics"},{"key":"ref_148","doi-asserted-by":"crossref","unstructured":"Papadaki, M.A., Koutsopoulos, A.V., Tsoulfas, P.G., Lagoudaki, E., Aggouraki, D., Monastirioti, A., Koutoulaki, C., Apostolopoulou, C.A., Merodoulaki, A.C., and Papadaki, C. (2020). Clinical relevance of immune checkpoints on circulating tumor cells in breast cancer. Cancers, 12.","DOI":"10.3390\/cancers12020376"},{"key":"ref_149","doi-asserted-by":"crossref","unstructured":"Freitas, A.J.A.d., Causin, R.L., Varuzza, M.B., Calfa, S., Hidalgo Filho, C.M.T., Komoto, T.T., Souza, C.d.P., and Marques, M.M.C. (2022). Liquid Biopsy as a Tool for the Diagnosis, Treatment, and Monitoring of Breast Cancer. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23179952"},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"531","DOI":"10.4143\/crt.2022.221","article-title":"PIK3CA Mutation is Associated with Poor Response to HER2-Targeted Therapy in Breast Cancer Patients","volume":"55","author":"Kim","year":"2023","journal-title":"Cancer Res. Treat."},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1272\/jnms.JNMS.2022_89-107","article-title":"PIK3CA mutation detected by liquid biopsy in patients with metastatic breast cancer","volume":"89","author":"Nakai","year":"2021","journal-title":"J. Nippon Med. Sch."},{"key":"ref_152","doi-asserted-by":"crossref","unstructured":"Venetis, K., CursanSo, G., Pescia, C., D\u2019Ercole, M., Porta, F.M., Blanco, M.C., Frascarelli, C., Ivanova, M., Guerini Rocco, E., and Fusco, N. (2023). Liquid biopsy: Cell-free DNA based analysis in breast cancer. J. Liq. Biopsy, 1.","DOI":"10.1016\/j.jlb.2023.100002"},{"key":"ref_153","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.annonc.2020.11.011","article-title":"Alpelisib plus fulvestrant for PIK3CA-mutated, hormone receptor-positive, human epidermal growth factor receptor-2\u2013negative advanced breast cancer: Final overall survival results from SOLAR-1","volume":"32","author":"Ciruelos","year":"2021","journal-title":"Ann. Oncol."},{"key":"ref_154","doi-asserted-by":"crossref","first-page":"158","DOI":"10.26502\/fjhs.174","article-title":"PIK3CA Mutational Profiling in a Patient Cohort with HR+\/HER2-Advanced Metastatic Breast Cancer at a Tertiary Cancer Center","volume":"7","author":"Alsmadi","year":"2024","journal-title":"Fortune J. Health Sci."},{"key":"ref_155","doi-asserted-by":"crossref","unstructured":"Liao, H., Huang, W., Pei, W., and Li, H. (2020). Detection of ESR1 mutations based on liquid biopsy in estrogen receptor-positive metastatic breast cancer: Clinical impacts and prospects. Front. Oncol., 10.","DOI":"10.3389\/fonc.2020.587671"},{"key":"ref_156","doi-asserted-by":"crossref","unstructured":"Urso, L., Vernaci, G., Carlet, J., Lo Mele, M., Fassan, M., Zulato, E., Faggioni, G., Menichetti, A., Di Liso, E., and Griguolo, G. (2021). ESR1 gene mutation in hormone receptor-positive HER2-negative metastatic breast cancer patients: Concordance between tumor tissue and circulating tumor DNA analysis. Front. Oncol., 11.","DOI":"10.3389\/fonc.2021.625636"},{"key":"ref_157","doi-asserted-by":"crossref","unstructured":"Mazouji, O., Ouhajjou, A., Incitti, R., and Mansour, H. (2021). Updates on clinical use of liquid biopsy in colorectal cancer screening, diagnosis, follow-up, and treatment guidance. Front. Cell Dev. Biol., 9.","DOI":"10.3389\/fcell.2021.660924"},{"key":"ref_158","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1097\/MOG.0000000000000688","article-title":"Noninvasive strategies for colorectal cancer screening: Opportunities and limitations","volume":"37","author":"Lou","year":"2021","journal-title":"Curr. Opin. Gastroenterol."},{"key":"ref_159","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1016\/j.cgh.2022.12.008","article-title":"Emerging tests for noninvasive colorectal cancer screening","volume":"21","author":"Hanna","year":"2023","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"ref_160","doi-asserted-by":"crossref","first-page":"e00088","DOI":"10.14309\/ctg.0000000000000088","article-title":"Novel Circulating Tumor Cell Assay for Detection of Colorectal Adenomas and Cancer","volume":"10","author":"Tsai","year":"2019","journal-title":"Clin. Transl. Gastroenterol."},{"key":"ref_161","doi-asserted-by":"crossref","first-page":"S190","DOI":"10.1016\/j.bj.2020.09.006","article-title":"Circulating tumor cell enumeration for improved screening and disease detection of patients with colorectal cancer","volume":"44","author":"Tsai","year":"2021","journal-title":"Biomed. J."},{"key":"ref_162","doi-asserted-by":"crossref","unstructured":"Ding, Y., Li, W., Wang, K., Xu, C., Hao, M., and Ding, L. (2020). Perspectives of the application of liquid biopsy in colorectal cancer. BioMed Res. Int., 2020.","DOI":"10.1155\/2020\/6843180"},{"key":"ref_163","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1007\/s40291-020-00473-8","article-title":"Epi proColon\u00ae for colorectal cancer screening: A profile of its use in the USA","volume":"24","author":"Shirley","year":"2020","journal-title":"Mol. Diagn. Ther."},{"key":"ref_164","doi-asserted-by":"crossref","unstructured":"Kamel, F., Eltarhoni, K., Nisar, P., and Soloviev, M. (2022). Colorectal Cancer Diagnosis: The Obstacles We Face in Determining a Non-Invasive Test and Current Advances in Biomarker Detection. Cancers, 14.","DOI":"10.3390\/cancers14081889"},{"key":"ref_165","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1053\/j.gastro.2024.02.012","article-title":"Effectiveness and Cost-Effectiveness of Colorectal Cancer Screening with a Blood Test That Meets the Centers for Medicare & Medicaid Services Coverage Decision","volume":"167","author":"Knudsen","year":"2024","journal-title":"Gastroenterology"},{"key":"ref_166","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/s00384-020-03757-x","article-title":"DNA methylation markers detected in blood, stool, urine, and tissue in colorectal cancer: A systematic review of paired samples","volume":"36","author":"Laugsand","year":"2021","journal-title":"Int. J. Colorectal Dis."},{"key":"ref_167","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1093\/clinchem\/hvad198","article-title":"Screening for Colorectal Cancer: The Role of Clinical Laboratories","volume":"70","author":"Toth","year":"2024","journal-title":"Clin. Chem."},{"key":"ref_168","doi-asserted-by":"crossref","first-page":"2068","DOI":"10.1002\/ijc.34186","article-title":"DNA methylation biomarkers in colorectal cancer: Clinical applications for precision medicine","volume":"151","author":"Fatemi","year":"2022","journal-title":"Int. J. Cancer"},{"key":"ref_169","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1186\/s12943-024-02063-2","article-title":"Clinical application of liquid biopsy in colorectal cancer: Detection, prediction, and treatment monitoring","volume":"23","author":"Tao","year":"2024","journal-title":"Mol. Cancer"},{"key":"ref_170","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1080\/0284186X.2020.1806357","article-title":"Circulating tumor DNA as a marker of minimal residual disease following local treatment of metastases from colorectal cancer","volume":"59","author":"Boysen","year":"2020","journal-title":"Acta Oncol."},{"key":"ref_171","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1158\/1078-0432.CCR-20-2299","article-title":"Serial Circulating Tumor DNA in Predicting and Monitoring the Effect of Neoadjuvant Chemoradiotherapy in Patients with Rectal Cancer: A Prospective Multicenter Study","volume":"27","author":"Zhou","year":"2021","journal-title":"Clin. Cancer Res."},{"key":"ref_172","doi-asserted-by":"crossref","unstructured":"Movassaghi, M., Chung, R., Anderson, C.B., Stein, M., Saenger, Y., and Faiena, I. (2021). Overcoming Immune Resistance in Prostate Cancer: Challenges and Advances. Cancers, 13.","DOI":"10.3390\/cancers13194757"},{"key":"ref_173","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1080\/17425255.2024.2353749","article-title":"New-generation androgen receptor signaling inhibitors (ARSIs) in metastatic hormone-sensitive prostate cancer (mHSPC): Pharmacokinetics, drug-drug interactions (DDIs), and clinical impact","volume":"20","author":"Gasperoni","year":"2024","journal-title":"Expert Opin. Drug Metab. Toxicol."},{"key":"ref_174","doi-asserted-by":"crossref","first-page":"2926","DOI":"10.1200\/JCO.21.00169","article-title":"Prospective Evaluation of Clinical Outcomes Using a Multiplex Liquid Biopsy Targeting Diverse Resistance Mechanisms in Metastatic Prostate Cancer","volume":"39","author":"Sperger","year":"2021","journal-title":"J. Clin. Oncol."},{"key":"ref_175","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1007\/s11912-022-01278-0","article-title":"Integration of Liquid Biopsies in Clinical Management of Metastatic Prostate Cancer","volume":"24","author":"Tulpule","year":"2022","journal-title":"Curr. Oncol. Rep."},{"key":"ref_176","doi-asserted-by":"crossref","unstructured":"Ionescu, F., Zhang, J., and Wang, L. (2022). Clinical Applications of Liquid Biopsy in Prostate Cancer: From Screening to Predictive Biomarker. Cancers, 14.","DOI":"10.3390\/cancers14071728"},{"key":"ref_177","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1038\/s41388-022-02179-z","article-title":"Targeting a splicing-mediated drug resistance mechanism in prostate cancer by inhibiting transcriptional regulation by PKC\u03b21","volume":"41","author":"Melnyk","year":"2022","journal-title":"Oncogene"},{"key":"ref_178","doi-asserted-by":"crossref","first-page":"13","DOI":"10.33393\/jcb.2020.2163","article-title":"Development of an immunofluorescent AR-V7 circulating tumor cell assay-A blood-based test for men with metastatic prostate cancer","volume":"9","author":"Lu","year":"2020","journal-title":"J. Circ. Biomark."},{"key":"ref_179","doi-asserted-by":"crossref","unstructured":"Liu, H.E., Vuppalapaty, M., Hoerner, C.R., Bergstrom, C.P., Chiu, M., Lemaire, C., Che, J., Kaur, A., Dimmick, A., and Liu, S. (2024). Detecting androgen receptor (AR), AR variant 7 (AR-V7), prostate-specific membrane antigen (PSMA), and prostate-specific antigen (PSA) gene expression in CTCs and plasma exosome-derived cfRNA in patients with metastatic castration-resistant prostate cancer (mCRPC) by integrating the VTX-1 CTC isolation system with the QIAGEN AdnaTest. BMC Cancer, 24.","DOI":"10.1186\/s12885-024-12139-3"},{"key":"ref_180","doi-asserted-by":"crossref","unstructured":"Nimir, M., Ma, Y., Jeffreys, S.A., Opperman, T., Young, F., Khan, T., Ding, P., Chua, W., Balakrishnar, B., and Cooper, A. (2019). Detection of AR-V7 in Liquid Biopsies of Castrate Resistant Prostate Cancer Patients: A Comparison of AR-V7 Analysis in Circulating Tumor Cells, Circulating Tumor RNA and Exosomes. Cells, 8.","DOI":"10.3390\/cells8070688"},{"key":"ref_181","unstructured":"Abida, W., Antonarakis, E., and Sartor, A.O. (2023). Management of Advanced Prostate Cancer with Germline or Somatic Homologous Recombination Repair Deficiency, UpToDate."},{"key":"ref_182","first-page":"1639","article-title":"PARP Inhibition in Prostate Cancer with Homologous Recombination Repair Alterations","volume":"5","author":"Brandt","year":"2021","journal-title":"JCO Precis. Oncol."},{"key":"ref_183","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1093\/oncolo\/oyab053","article-title":"Homologous Recombination Deficiency: Concepts, Definitions, and Assays","volume":"27","author":"Stewart","year":"2022","journal-title":"Oncologist"},{"key":"ref_184","doi-asserted-by":"crossref","unstructured":"Woodhouse, R., Li, M., Hughes, J., Delfosse, D., Skoletsky, J., Ma, P., Meng, W., Dewal, N., Milbury, C., and Clark, T. (2020). Clinical and analytical validation of FoundationOne Liquid CDx, a novel 324-Gene cfDNA-based comprehensive genomic profiling assay for cancers of solid tumor origin. PLoS ONE, 15.","DOI":"10.1371\/journal.pone.0237802"},{"key":"ref_185","doi-asserted-by":"crossref","unstructured":"Mekonnen, N., Yang, H., and Shin, Y.K. (2022). Homologous recombination deficiency in ovarian, breast, colorectal, pancreatic, non-small cell lung and prostate cancers, and the mechanisms of resistance to PARP inhibitors. Front. Oncol., 12.","DOI":"10.3389\/fonc.2022.880643"},{"key":"ref_186","first-page":"290","article-title":"Predictive biomarkers in advanced prostate cancer","volume":"6","author":"Armstrong","year":"2023","journal-title":"Clin. Adv. Hematol. Oncol. HO"},{"key":"ref_187","doi-asserted-by":"crossref","first-page":"e2300654","DOI":"10.1200\/PO.23.00654","article-title":"Toward Informed Selection and Interpretation of Clinical Genomic Tests in Prostate Cancer","volume":"8","author":"Vandekerkhove","year":"2024","journal-title":"JCO Precis. Oncol."},{"key":"ref_188","doi-asserted-by":"crossref","first-page":"3263","DOI":"10.1039\/D1LC00485A","article-title":"The role of liquid biopsies in prostate cancer management","volume":"21","author":"Kim","year":"2021","journal-title":"Lab Chip"},{"key":"ref_189","doi-asserted-by":"crossref","unstructured":"de Kruijff, I.E., Sieuwerts, A.M., Onstenk, W., Kraan, J., Smid, M., Van, M.N., van der Vlugt-Daane, M., Oomen-de Hoop, E., Mathijssen, R.H.J., and Lolkema, M.P. (2019). Circulating Tumor Cell Enumeration and Characterization in Metastatic Castration-Resistant Prostate Cancer Patients Treated with Cabazitaxel. Cancers, 11.","DOI":"10.3390\/cancers11081212"},{"key":"ref_190","doi-asserted-by":"crossref","unstructured":"Nagaya, N., Nagata, M., Lu, Y., Kanayama, M., Hou, Q., Hotta, Z.-u., China, T., Kitamura, K., Matsushita, K., and Isotani, S. (2020). Prostate-specific membrane antigen in circulating tumor cells is a new poor prognostic marker for castration-resistant prostate cancer. PLoS ONE, 15.","DOI":"10.1371\/journal.pone.0226219"},{"key":"ref_191","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1111\/bju.14642","article-title":"Phenotypes of circulating tumour cells predict time to castration resistance in metastatic castration-sensitive prostate cancer","volume":"124","author":"Yang","year":"2019","journal-title":"BJU Int."},{"key":"ref_192","doi-asserted-by":"crossref","unstructured":"Shoukry, M., Broccard, S., Kaplan, J., and Gabriel, E. (2021). The Emerging Role of Circulating Tumor DNA in the Management of Breast Cancer. Cancers, 13.","DOI":"10.3390\/cancers13153813"},{"key":"ref_193","doi-asserted-by":"crossref","unstructured":"Vacante, M., Ciuni, R., Burzotta, F., and Biondi, A. (2020). The Liquid Biopsy in the Management of Colorectal Cancer: An Overview. Biomedicines, 8.","DOI":"10.3390\/biomedicines8090308"},{"key":"ref_194","doi-asserted-by":"crossref","unstructured":"Palac\u00edn-Aliana, I., Garc\u00eda-Romero, N., Asensi-Puig, A., Carri\u00f3n-Navarro, J., Gonz\u00e1lez-Rumayor, V., and Ayuso-Sacido, \u00c1. (2021). Clinical Utility of Liquid Biopsy-Based Actionable Mutations Detected via ddPCR. Biomedicines, 9.","DOI":"10.3390\/biomedicines9080906"},{"key":"ref_195","doi-asserted-by":"crossref","unstructured":"Nordg\u00e5rd, O., Forthun, R.B., Lapin, M., Gr\u00f8nberg, B.H., Kalland, K.H., Kopperud, R.K., Thomsen, L.C.V., Tjensvoll, K., Gilje, B., and Gjertsen, B.T. (2021). Liquid Biopsies in Solid Cancers: Implementation in a Nordic Healthcare System. Cancers, 13.","DOI":"10.3390\/cancers13081861"},{"key":"ref_196","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1111\/cts.12657","article-title":"The Labyrinth of Product Development and Regulatory Approvals in Liquid Biopsy Diagnostics","volume":"12","author":"Goodsaid","year":"2019","journal-title":"Clin. Transl. Sci."},{"key":"ref_197","doi-asserted-by":"crossref","unstructured":"Paracchini, L., D\u2019Incalci, M., and Marchini, S. (2021). Liquid Biopsy in the Clinical Management of High-Grade Serous Epithelial Ovarian Cancer\u2014Current Use and Future Opportunities. Cancers, 13.","DOI":"10.3390\/cancers13102386"},{"key":"ref_198","doi-asserted-by":"crossref","unstructured":"Kan, C.M., Tsang, H.F., Pei, X.M., Ng, S.S.M., Yim, A.K., Yu, A.C., and Wong, S.C.C. (2024). Enhancing Clinical Utility: Utilization of International Standards and Guidelines for Metagenomic Sequencing in Infectious Disease Diagnosis. Int. J. Mol. Sci., 25.","DOI":"10.3390\/ijms25063333"},{"key":"ref_199","doi-asserted-by":"crossref","unstructured":"Temilola, D.O., Wium, M., Coulidiati, T.H., Adeola, H.A., Carbone, G.M., Catapano, C.V., and Zerbini, L.F. (2019). The Prospect and Challenges to the Flow of Liquid Biopsy in Africa. Cells, 8.","DOI":"10.3390\/cells8080862"},{"key":"ref_200","doi-asserted-by":"crossref","first-page":"e000528","DOI":"10.1136\/esmoopen-2019-000528","article-title":"Liquid Biopsy Assessment of Synchronous Malignancies: A Case Report and Review of the Literature","volume":"4","author":"Liebs","year":"2019","journal-title":"Esmo Open"},{"key":"ref_201","doi-asserted-by":"crossref","first-page":"e564","DOI":"10.1002\/mco2.564","article-title":"Liquid Biopsy for Human Cancer: Cancer Screening, Monitoring, and Treatment","volume":"5","author":"Wang","year":"2024","journal-title":"Medcomm"},{"key":"ref_202","first-page":"325","article-title":"Liquid Biopsy\u2014A Novel Diagnostic Tool for Management of Early-Stage Peripheral Lung Cancer","volume":"76","author":"Pupola","year":"2022","journal-title":"Proc. Latv. Acad. Sci. Sect. B Nat. Exact. Appl. Sci."},{"key":"ref_203","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1016\/j.annonc.2021.04.012","article-title":"Practical Considerations in Screening for Genetic Alterations in Cholangiocarcinoma","volume":"32","author":"Bridgewater","year":"2021","journal-title":"Ann. Oncol."},{"key":"ref_204","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1038\/s41416-022-01881-9","article-title":"Blood-Based Liquid Biopsies for Prostate Cancer: Clinical Opportunities and Challenges","volume":"127","author":"Trujillo","year":"2022","journal-title":"Br. J. Cancer"},{"key":"ref_205","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1111\/cas.16097","article-title":"Beyond Blood: Advancing the Frontiers of Liquid Biopsy in Oncology and Personalized Medicine","volume":"115","author":"Bao","year":"2024","journal-title":"Cancer Sci."},{"key":"ref_206","doi-asserted-by":"crossref","first-page":"e20230021","DOI":"10.1002\/INMD.20230021","article-title":"Recent Advances of Liquid Biopsy: Interdisciplinary Strategies Toward Clinical Decision-making","volume":"1","author":"Bao","year":"2023","journal-title":"Interdiscip. Med."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/25\/16\/8594\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T15:31:10Z","timestamp":1760110270000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/25\/16\/8594"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,6]]},"references-count":206,"journal-issue":{"issue":"16","published-online":{"date-parts":[[2024,8]]}},"alternative-id":["ijms25168594"],"URL":"https:\/\/doi.org\/10.3390\/ijms25168594","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,6]]}}}